• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 6-K filed by Inspira Technologies Oxy B.H.N. Ltd.

    5/27/25 4:01:34 PM ET
    $IINN
    Medical/Dental Instruments
    Health Care
    Get the next $IINN alert in real time by email
    6-K 1 ea0243475-6k_inspira.htm REPORT OF FOREIGN PRIVATE ISSUER

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    FORM 6-K

     

    REPORT OF FOREIGN PRIVATE ISSUER

    PURSUANT TO RULE 13a-16 OR 15d-16

    UNDER THE SECURITIES EXCHANGE ACT OF 1934

     

    For the Month of: May 2025 (Report No. 3)

     

    Commission File Number: 001-40303

     

    Inspira Technologies Oxy B.H.N. Ltd.

    (Translation of registrant’s name into English)

     

    2 Ha-Tidhar St.

    Ra’anana 4366504, Israel

    (Address of principal executive office)

     

    Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

     

    ☒ Form 20-F      ☐ Form 40-F

     

     

     

     

     

    CONTENTS

     

    On May 27, 2025, Inspira Technologies Oxy B.H.N. Ltd. (the “Company”) issued a press release titled “Inspira Technologies Aligns Executive Team Amid Corporate Structuring Initiatives,” a copy of which is furnished as Exhibit 99.1 with this report of foreign private issuer on Form 6-K.

     

    The first, second, fifth and sixth paragraphs and the section titled “Forward-Looking Statements” in the press release are incorporated by reference into the Registrant’s Registration Statements on Form F-3 (Registration Nos. 333-266748 and 333-284308) and Form S-8 (Registration Nos. 333-259057 and 333-277980 and 333-285565), filed with the Securities and Exchange Commission, to be a part thereof from the date on which this Report of Foreign Private Issuer on Form 6-K is submitted, to the extent not superseded by documents or reports subsequently filed or furnished. 

     

    Exhibit No.    
    99.1   Press Release issued by Inspira Technologies Oxy B.H.N. Ltd. on May 27, 2025, titled “Inspira Technologies Aligns Executive Team Amid Corporate Structuring Initiatives.”

     

    1

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

     

      Inspira Technologies Oxy B.H.N. Ltd.
         
    Date: May 27, 2025 By: /s/ Dagi Ben-Noon
        Name:   Dagi Ben-Noon
        Title: Chief Executive Officer

     

    2

    Get the next $IINN alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $IINN

    DatePrice TargetRatingAnalyst
    11/1/2021$9.00 → $10.00Buy
    Aegis Capital
    8/26/2021$9.00Buy
    Aegis Capital
    More analyst ratings

    $IINN
    SEC Filings

    See more
    • SEC Form 6-K filed by Inspira Technologies Oxy B.H.N. Ltd.

      6-K - Inspira Technologies OXY B.H.N. Ltd (0001837493) (Filer)

      5/30/25 4:02:08 PM ET
      $IINN
      Medical/Dental Instruments
      Health Care
    • SEC Form 6-K filed by Inspira Technologies Oxy B.H.N. Ltd.

      6-K - Inspira Technologies OXY B.H.N. Ltd (0001837493) (Filer)

      5/29/25 9:23:47 AM ET
      $IINN
      Medical/Dental Instruments
      Health Care
    • SEC Form 6-K filed by Inspira Technologies Oxy B.H.N. Ltd.

      6-K - Inspira Technologies OXY B.H.N. Ltd (0001837493) (Filer)

      5/27/25 4:01:34 PM ET
      $IINN
      Medical/Dental Instruments
      Health Care

    $IINN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Aegis Capital reiterated coverage on Inspira Technologies Oxy with a new price target

      Aegis Capital reiterated coverage of Inspira Technologies Oxy with a rating of Buy and set a new price target of $10.00 from $9.00 previously

      11/1/21 12:39:26 PM ET
      $IINN
      Medical/Dental Instruments
      Health Care
    • Aegis Capital initiated coverage on Inspira Technologies Oxy with a new price target

      Aegis Capital initiated coverage of Inspira Technologies Oxy with a rating of Buy and set a new price target of $9.00

      8/26/21 10:05:11 AM ET
      $IINN
      Medical/Dental Instruments
      Health Care

    $IINN
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Inspira Technologies Initiates Global Commercial Rollout of FDA-Cleared ART100 System

      RA'ANANA, Israel, May 29, 2025 (GLOBE NEWSWIRE) -- Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ:IINN) ("Inspira" or the "Company"), a pioneer in innovative life-support and diagnostic technologies, today announced a strategic shift to accelerate the commercialization of its U.S. FDA (Food and Drug Administration)-cleared INSPIRA™ ART100 system (the "ART100"), while maintaining the development and regulatory pathways of its portfolio of products. The Company is currently engaged in active sales discussions in multiple locations. This development follows the initial clinical implementation of the ART100 system in medical centers in the U.S., where the device has been used to treat patients

      5/29/25 9:15:00 AM ET
      $IINN
      Medical/Dental Instruments
      Health Care
    • Inspira Technologies Aligns Executive Team Amid Corporate Structuring Initiatives

      RA'ANANA, Israel, May 27, 2025 (GLOBE NEWSWIRE) -- Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ:IINN) ("Inspira" or the "Company"), a pioneering company in advanced respiratory support and diagnostic systems, today announced an evolution in its executive structure that reflects recent internal assessments and long-term strategic alignment efforts. Mr. Joe Hayon, Co-Founder and President of Inspira, will be stepping down from his operational role as President of Inspira, and will continue to serve as an active Board member. The decision not to appoint a successor to the President role signals a streamlined leadership framework aimed at reinforcing operational clarity and strategic flexibi

      5/27/25 8:30:00 AM ET
      $IINN
      Medical/Dental Instruments
      Health Care
    • INSPIRA ART100 System Approved by Israel's Largest Healthcare Provider for Use in Organ Transplant Patients

      RA'ANANA, Israel, May 07, 2025 (GLOBE NEWSWIRE) -- Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ:IINN) ("Inspira" or the "Company"), a pioneer in innovative life-support and diagnostic technologies, today announced that the INSPIRA™ ART100 has been approved by Israel's largest healthcare provider to undergo a clinical validation by leading physicians who intend to use the innovative life-support and diagnostic device during organ transplant procedures.  As part of this advancement, Inspira will deploy the U.S. Food and Drug Administration ("FDA") approved INSPIRA ART100 system at one of Israel's renowned medical centers affiliated with the largest health care provider. A team of pioneeri

      5/7/25 8:45:00 AM ET
      $IINN
      Medical/Dental Instruments
      Health Care

    $IINN
    Financials

    Live finance-specific insights

    See more
    • Inspira Technologies Reports Full Year 2024 Financial Results and Provides Business Updates

      Significant progress in HYLA blood sensor and INSPIRA ART core technologies RA'ANANA, Israel, March 11, 2025 /PRNewswire/ -- Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ:IINN) ("Inspira" or the "Company"), a pioneer in innovative life-support and diagnostic technologies, today announced its financial results for the full year ended December 31, 2024, and provided a corporate update. Dagi Ben-Noon, Chief Executive Officer of Inspira, commented: "2024 was a transformative year for Inspira, marked by significant technological advancements and a major regulatory milestone. We successfully obtained 510(k) clearance from the Food and Drug Administration ("FDA") for our INSPIRA™ ART100 system an

      3/11/25 8:30:00 AM ET
      $IINN
      Medical/Dental Instruments
      Health Care
    • Inspira™ Announces Business Plan Targets

      Company to aggressively promote INSPIRA™ ART100 in the U.S. and additional markets following FDA clearance, as well as accelerate plans for ground-breaking INSPIRA™ ART (Gen2) RA'ANANA, Israel, June 20, 2024 /PRNewswire/ -- Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ:IINN), (NASDAQ:IINNW) (the "Company" or "Inspira"), a breakthrough medical technology company, announced today that the Company's President and co-founder, Mr. Joe Hayon, presented a business plan with targets for the Company's next-generation technologies on a Company conference call today.     On the call, Inspira unveiled plans to build an opportunity for a share of the $19 billion mechanical ventilation market. Inspira's

      6/20/24 9:25:00 AM ET
      $IINN
      Medical/Dental Instruments
      Health Care
    • Inspira™ to Exhibit the FDA Cleared INSPIRA™ ART100 System at a World-Renowned Event in the Sector

      The event is an opportunity to present and demonstrate new products and technologies to potential customers and strategic partners RA'ANANA, Israel, June 5, 2024 /PRNewswire/ -- Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ:IINN) (NASDAQ:IINNW) (the "Company" or "Inspira Technologies"), a breakthrough medical technology company, is proud to announce plans to exhibit the INSPIRA™ ART100 System, recently cleared by the U.S. Food and Drug Administration ("FDA"), at the Extracorporeal Life Support Organization (ELSO) conference in Detroit, Michigan between September 29 to October 1, 2024. This event provides the Company with an opportunity to present the system in front of healthcare representa

      6/5/24 8:30:00 AM ET
      $IINN
      Medical/Dental Instruments
      Health Care

    $IINN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Inspira Technologies Oxy B.H.N. Ltd.

      SC 13G/A - Inspira Technologies OXY B.H.N. Ltd (0001837493) (Subject)

      11/14/24 4:08:42 PM ET
      $IINN
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13G filed by Inspira Technologies Oxy B.H.N. Ltd.

      SC 13G - Inspira Technologies OXY B.H.N. Ltd (0001837493) (Subject)

      2/14/24 3:40:01 PM ET
      $IINN
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13G/A filed by Inspira Technologies Oxy B.H.N. Ltd. (Amendment)

      SC 13G/A - Inspira Technologies OXY B.H.N. Ltd (0001837493) (Subject)

      2/12/24 4:05:09 PM ET
      $IINN
      Medical/Dental Instruments
      Health Care

    $IINN
    Leadership Updates

    Live Leadership Updates

    See more
    • PESG Report: Inspira Technologies Strengthens its AI-Powered Blood Sensor with new Capabilities, Intends to Share Clinical Findings Soon

      Inspira Technologies* advancement of its AI-powered blood monitoring technology comes amid robust growth in medical technology M&A, with Q3 2024 seeing 275 deals worth $34 billion - a 35% increase year-over-year. The integration of this new oxygenation indicator strengthens the Company's position in both the $2.5 billion blood gas analysis market and, through the FDA-cleared INSPIRA ART100 system, the $19 billion mechanical ventilation market. With clinical evaluations of the HYLA blood sensor underway at Sheba Medical Center and preliminary results reportedly expected in the near future, the Company continues to execute its strategy of combining AI-enhanced monitoring capabilities with inn

      2/6/25 8:27:00 AM ET
      $IINN
      Medical/Dental Instruments
      Health Care
    • Inspira™ Announces the Appointment of Tal Parnes as the New Chairman of the Board, Bringing Vast Experience in the Medical Technology and Pharmaceutical Sectors

      RA'ANANA, Israel, Jan. 21, 2025 /PRNewswire/ -- Inspira Technologies OXY B.H.N. Ltd. (NASDAQ:IINN) (Nasdaq: IINNW) ("Inspira" or the "Company"), a leader in life-support technology innovation, has announced the appointment of Mr. Tal Parnes as the new chairman of the board of directors, effective February 1, 2025.     Mr. Parnes brings a wealth of experience and expertise to his new role at Inspira. With a distinguished career spanning over three decades in the technology sector, with a special focus in the medical technology and pharmaceutical industries, Mr. Parnes has consistently demonstrated exceptional leadership and strategic vision. As a serial entrepreneur, Parnes has demonstrated

      1/21/25 8:30:00 AM ET
      $IINN
      Medical/Dental Instruments
      Health Care
    • In Preparation for FDA Clearance and Device Deployment, Inspira has Appointed Dr. Dan Gorfil, to Medical Advisory Board

      RA'ANANA, Israel, Dec. 11, 2023 /PRNewswire/ -- Inspira Technologies OXY B.H.N. Ltd. (NASDAQ:IINN) (NASDAQ:IINNW) (the "Company" or "Inspira"), a pioneer in life support technology with a vision to supersede traditional mechanical ventilators, is pleased to announce the appointment of Dr. Dan Gorfil to its medical advisory board. Dr. Gorfil is a distinguished specialist in cardiac surgery and intensive care medicine. Dr. Gorfil is both the head of the Cardiothoracic Surgery Intensive Care Unit and the Extracorporeal Membrane Oxygenation program at the Department of Cardiothoracic Surgery at Rabin Medical Center, Israel. Dr. Gorfil's expertise are expected to significantly contribute to the

      12/11/23 9:00:00 AM ET
      $IINN
      Medical/Dental Instruments
      Health Care